Opinion

Video

Ongoing Trial(s) for Intracranial Progression in Advanced HER2+ Breast Cancer

Panelists discuss the design and rationale of the ongoing BRIDGET (NCT05323955) trial, focusing on how its outcomes could potentially shape the future treatment landscape for HER2-positive breast cancer, particularly in patients with brain metastases.

Related Videos
5 experts are featured in this series
5 experts are featured in this series
4 experts are featured in this series.
2 expert is featured in this series.
4 experts are featured in this series.
Related Content